» Articles » PMID: 34301211

Construction and Comprehensive Analysis of a CeRNA Network to Reveal Potential Prognostic Biomarkers for Lung Adenocarcinoma

Overview
Journal BMC Cancer
Publisher Biomed Central
Specialty Oncology
Date 2021 Jul 24
PMID 34301211
Citations 13
Authors
Affiliations
Soon will be listed here.
Abstract

Background: More and more studies have proven that circular RNAs (circRNAs) play vital roles in cancer development via sponging miRNAs. However, the expression pattern of competing endogenous RNA (ceRNA) in lung adenocarcinoma (LUAD) remains largely unclear. The current study explored functional roles and the regulatory mechanisms of circRNA as ceRNAs in LUAD and their potential impact on LUAD patient prognosis.

Methods: In this study, we systematically screened differential expression circRNAs (DEcircRNAs), miRNAs (DEmiRNAs) and mRNAs (DEGs) associated with LUAD. Then, DEcircRNAs, DEmiRNAs and DEGs were selected to construct a circRNA-miRNA-mRNA prognosis-related regulatory network based on interaction information from the ENCORI database. Subsequently, the gene ontology (GO) and Kyoto Encyclopedia of Genes and Genomes (KEGG) pathway enrichment analysis were performed on the genes in the network to predict the potential underlying mechanisms and functions of circRNAs in LUAD. In addition, Kaplan-Meier survival analysis was performed to evaluate clinical outcomes of LUAD patients, and drug sensitivity analysis was used to screen potential biomarkers for drug treatment of patients with LUAD.

Results: As a result, 10 circRNAs were aberrantly expressed in LUAD tissues. The ceRNA network was built, which included 3 DEcircRNAs, 6 DEmiRNAs and 157 DEGs. The DEGs in the ceRNA network of hsa_circ_0049271 enriched in biological processes of cell proliferation and the Jak-STAT signaling pathway. We also detected 7 mRNAs in the ceRNA network of hsa_circ_0049271 that were significantly associated with the overall survival of LUAD patients (P < 0.05). Importantly, four genes (PDGFB, CCND2, CTF1, IL7R) identified were strongly associated with STAT3 activation and drugs sensitivity in GDSC.

Conclusions: In summary, a ceRNA network of hsa_circ_0049271 was successfully constructed, which including one circRNA, two miRNAs, and seven mRNAs. Seven mRNAs (PDGFB, TNFRSF19, CCND2, CTF1, IL11RA, IL7R and MAOA) were remarkably associated with the prognosis of LUAD patients. Among seven mRNA species, four genes (PDGFB, CCND2, CTF1, and IL7R) could be considered as drug targets in LUAD. Our research will provide new insights into the prognosis-related ceRNA network in LUAD.

Citing Articles

Prognostic value of CTF1 in glioma and its role in the tumor microenvironment.

He J, Guo J, Sun P Transl Cancer Res. 2025; 13(12):6862-6879.

PMID: 39816535 PMC: 11730202. DOI: 10.21037/tcr-24-1258.


Relationship between CTF1 gene expression and prognosis and tumor immune microenvironment in glioma.

Cai H, Tian S, Liu A, Xie G, Zhang H, Wu X Eur J Med Res. 2025; 30(1):17.

PMID: 39780198 PMC: 11715937. DOI: 10.1186/s40001-024-02192-w.


The bioinformatics analysis and experimental validation of the carcinogenic role of EXO1 in lung adenocarcinoma.

Sun B, Zhang J, Wang N, Zhang Z, Wu Y, Xie M Front Oncol. 2025; 14():1492725.

PMID: 39777332 PMC: 11703735. DOI: 10.3389/fonc.2024.1492725.


Identification of circRNA-miRNA-mRNA networks to explore underlying mechanism in lung cancer.

Wang Y, Fu Y Health Inf Sci Syst. 2024; 13(1):5.

PMID: 39676897 PMC: 11645342. DOI: 10.1007/s13755-024-00318-2.


Exploring the relationship between the interleukin family and lung adenocarcinoma through Mendelian randomization and RNA sequencing analysis.

Zhi F, Liu W, Yang H, Luo H, Feng Y, Lei Y Discov Oncol. 2024; 15(1):436.

PMID: 39264458 PMC: 11393260. DOI: 10.1007/s12672-024-01325-1.


References
1.
Glazar P, Papavasileiou P, Rajewsky N . circBase: a database for circular RNAs. RNA. 2014; 20(11):1666-70. PMC: 4201819. DOI: 10.1261/rna.043687.113. View

2.
Ritchie M, Phipson B, Wu D, Hu Y, Law C, Shi W . limma powers differential expression analyses for RNA-sequencing and microarray studies. Nucleic Acids Res. 2015; 43(7):e47. PMC: 4402510. DOI: 10.1093/nar/gkv007. View

3.
Kristensen L, Hansen T, Veno M, Kjems J . Circular RNAs in cancer: opportunities and challenges in the field. Oncogene. 2017; 37(5):555-565. PMC: 5799710. DOI: 10.1038/onc.2017.361. View

4.
Shang Q, Yang Z, Jia R, Ge S . The novel roles of circRNAs in human cancer. Mol Cancer. 2019; 18(1):6. PMC: 6325800. DOI: 10.1186/s12943-018-0934-6. View

5.
Rybak-Wolf A, Stottmeister C, Glazar P, Jens M, Pino N, Giusti S . Circular RNAs in the Mammalian Brain Are Highly Abundant, Conserved, and Dynamically Expressed. Mol Cell. 2015; 58(5):870-85. DOI: 10.1016/j.molcel.2015.03.027. View